I think quite a few of us had picked up on the potential ramifications of demedicalising transgenderism?
There is a mental health crisis in the UK. The symptoms are often body related, and the causes are complex, but a new orthodoxy now labels some of these people as transgender. This means that instead of getting psychological care, increasing numbers are encouraged to take potentially dangerous hormones on their way to transitioning gender. The World Health Organisation’s recent ruling that it will no longer classify being transgender as a mental illness is hailed by some as a progressive step forward. But could this shift in thinking actually compound matters and mean that transgender patients’ other medical issues are ignored?
The cocktail of hormones given to those who transition can make matters worse for those suffering from mental illness. Leuprorelin, which is used to reduce testosterone, can make those who take it feel ‘depressed’, according to Macmillan (the drug is also taken to treat cancer); yet this possible symptom appears to be a curious omission from this NHS guide to hormone therapy for trans people. This guidance also doesn’t mention that Cyproterone, a feminising hormone, can cause depression. Testosterone, which is used for female to male transition, is also linked to depression; while long term studies on athletic steroids, similar to some transition hormones, show ‘prolonged psychiatric effects’ and ‘toxicity’.
Yet despite doctors warning of a lack of research in this area, thousands of young people around the world receive doses of these hormones, not for months but in some cases for years. Make no mistake: these people have become guinea pigs in an experiment in which those who are sceptical are hounded into silence.
blogs.spectator.co.uk/2018/06/is-transgender-ideology-making-the-uks-mental-health-crisis-worse/